Literature DB >> 2261906

Papillary thyroid carcinoma.

I D Hay1.   

Abstract

Multiple prognostic factors for outcome in papillary thyroid carcinoma are identified. For a cohort of 1500 consecutive patients followed an average of 16 years, survival rates for tumor recurrence and cause-specific mortality are described. Risk groups derived from novel prognostic scoring or staging systems and the role of DNA ploidy testing are discussed specifically. Lastly, controversies are reviewed regarding the extent of primary surgical resection and the efficacy of postoperative radioiodine remnant ablation in papillary thyroid cancer.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2261906

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN： 0889-8529            Impact factor:   4.741


  60 in total

1.  Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.

Authors:  Ian D Hay; William M McConahey; John R Goellner
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes.

Authors:  C Regalbuto; P Malandrino; F Frasca; G Pellegriti; R Le Moli; R Vigneri; V Pezzino
Journal:  J Endocrinol Invest       Date:  2012-07-09       Impact factor: 4.256

Review 3.  Controversies in the Management of Low-Risk Differentiated Thyroid Cancer.

Authors:  Megan R Haymart; Nazanene H Esfandiari; Michael T Stang; Julia Ann Sosa
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 4.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

5.  Clinico-pathological characteristics and long-term outcome in patients with distant metastases from differentiated thyroid carcinoma.

Authors:  Vivek Aggarwal; P R K Bhargav; Anjali Mishra; Gaurav Agarwal
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 6.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

7.  Observational study of central metastases following thyroid lobectomy without a completion thyroidectomy for papillary carcinoma.

Authors:  Jin Seong Cho; Jung Han Yoon; Min Ho Park; Sun Hyoung Shin; Young Jong Jegal; Ji Shin Lee; Hee Kyung Kim
Journal:  J Korean Surg Soc       Date:  2012-09-25

8.  Clinical implication of cancer adhesion in papillary thyroid carcinoma: clinicopathologic characteristics and prognosis analyzed with degree of extrathyroidal extension.

Authors:  Seung Pil Jung; Minkuk Kim; Jun-Ho Choe; Jee Soo Kim; Seok Jin Nam; Jung-Han Kim
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

9.  [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens].

Authors:  A Larena; M Vierbuchen; S Schröder; A Larena-Avellaneda; I Hadshiew; R Fischer
Journal:  Langenbecks Arch Chir       Date:  1996

10.  Does the method of management of papillary thyroid carcinoma make a difference in outcome?

Authors:  L J DeGroot; E L Kaplan; F H Straus; M S Shukla
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.